Startseite Medizin Croatian laboratories have a good knowledge of the proper detection and management of hemolyzed, icteric and lipemic samples
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Croatian laboratories have a good knowledge of the proper detection and management of hemolyzed, icteric and lipemic samples

  • Nora Nikolac , Ivana Celap EMAIL logo , Petra Filipi , Marina Hemar , Marija Kocijancic , Marijana Miler , Ana-Maria Simundic , Vesna Supak Smolcic und Alen Vrtaric
Veröffentlicht/Copyright: 30. September 2015
Clinical Chemistry and Laboratory Medicine (CCLM)
Aus der Zeitschrift Clinical Chemistry and Laboratory Medicine (CCLM) Band 54 Heft 3

Abstract

Background: Endogenous interferences are an important source of biased laboratory results. Hemolysis, lipemia and icteria are the main source of endogenous interference in laboratory medicine. Accreditation according to ISO 15189 improves the overall quality of the laboratory procedures. The aim of our study was i) to assess the level of knowledge of Croatian medical biochemists about the proper detection and management of hemolysis, lipemia and icteria; and ii) to identify possible differences in the level of knowledge respective to the laboratory accreditation status.

Methods: An on-line self-report survey was carried out by the Working Group for Preanalytical Phase of the Croatian Society of Medical Biochemistry and Laboratory Medicine during April to May 2015. Survey included 14 statements (Q1–Q14) about procedures for samples with interferences and participants were asked to assess the degree of agreement with the statement using a 4-point Likert scale.

Results: The lowest level of knowledge was observed for statements Q10 (dealing with icteric sample; 40.9% participants agreed with the correct procedure), Q12 (allowable error for interference; 47.2%) and Q11 (dealing with lipemic sample; 60.1%). Almost all participants (97.4%) agreed that laboratories in Croatia should have a harmonized protocol for management of samples with interferences. Participants from accredited laboratories showed higher knowledge of hemolysis detection (p=0.031), rejection of hemolyzed sample (p<0.001), management of icteric samples (p=0.038) and allowable error for interferences (p=0.040).

Conclusions: Croatian laboratories have a good knowledge of the proper detection and management of hemolyzed, icteric and lipemic samples. Accreditation is associated with higher knowledge about management of samples with interferences.

Keywords: hemolysis; icteria; interferences; laboratory errors; lipemia; preanalytical phase; survey
Corresponding author: Ivana Celap, University Department of Chemistry, Sestre Milosrdnice University Hospital, Vinogradska 29, Zagreb, Croatia, Phone/Fax: +385-1-3768-280, E-mail: ; and Working Group for Preanalytical Phase of the Croatian Society of Medical Biochemistry and Laboratory Medicine, Zagreb, Croatia

References

1. Hallworth MJ. The ‘70% claim’: what is the evidence base? Ann Clin Biochem 2011;48:487–8.10.1258/acb.2011.011177Suche in Google Scholar PubMed

2. Bonini P, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin Chem 2002;48:691–8.10.1093/clinchem/48.5.691Suche in Google Scholar

3. Kroll MH, Elin RJ. Interference with clinical laboratory analyses. Clin Chem 1994;40:1996–2005.10.1093/clinchem/40.11.1996Suche in Google Scholar

4. Agarwal S, Vargas G, Nordsrtom C, Tam E, Buffone GJ, Devaraj S. Effect of interference from hemolysis. Icterus and lipemia on routine pediatric clinical chemistry assays. Clin Chim Acta 2015;438:241–5.10.1016/j.cca.2014.08.008Suche in Google Scholar PubMed

5. Ji JZ, Meng QH. Evaluation of the interference of haemoglobin, bilirubin, and lipids on Roche Cobas 6000 assays. Clin Chim Acta 2011;412:1550–3.10.1016/j.cca.2011.04.034Suche in Google Scholar PubMed

6. Simundic AM, Nikolac N, Vukasovic I, Vrkic N. The prevalence of preanalytical errors in Croatian ISO 15189 accredited laboratory. Clin Chem Lab Med 2010;48:1009–14.10.1515/CCLM.2010.221Suche in Google Scholar PubMed

7. Simundic AM, Topic E, Nikolac N, Lippi G. Hemolysis detection and management of hemolyzed specimens. Biochem Med (Zagreb) 2010;20:154–9.10.11613/BM.2010.018Suche in Google Scholar

8. Lippi G, Salvagno GL, Blanckaert N, Giavarina D, Green S, Kitchen S, et al. Multicenter evaluation of the hemolysis index in automated clinical chemistry systems. Clin Chem Lab Med 2009;47:934–9.10.1515/CCLM.2009.218Suche in Google Scholar PubMed

9. Clinical Laboratory Standards Institute. Interference testing in clinical chemistry; approved guideline. CLSI EP7-A2 document. Wayne, PA: Clinical Laboratory Standards Institute, 2005.Suche in Google Scholar

10. Clinical Laboratory Standards Institute. Hemolysis, icterus, and lipemia/turbidity indices as indicators of interference in clinical laboratory analysis; approved guideline. CLSI C56-A document. Wayne, PA: Clinical Laboratory Standards Institute, 2012.Suche in Google Scholar

11. Čvorišćec D. [Hemoliza]. Available from: http://www.hkmb.hr/povjerenstva/strucna-pitanja.html#11. Accessed: 10 Jun, 2015. [In Croatian].Suche in Google Scholar

12. Dukić L, Simundić AM. Institutional practices and policies in acid-base testing: a self reported Croatian survey study on behalf of the Croatian society of medical biochemistry and laboratory medicine Working Group for acid-base balance. Biochem Med (Zagreb) 2014;24:281–92.10.11613/BM.2014.031Suche in Google Scholar PubMed PubMed Central

13. Biljak VR, Honović L, Matica J, Knežević B, Vojak SŠ. Laboratory diagnostics of chronic kidney disease in Croatia: state of the art. Biochem Med (Zagreb) 2015;25:73–83.10.11613/BM.2015.009Suche in Google Scholar PubMed PubMed Central

14. Simundic AM, Church S, Cornes MP, Grankvist K, Lippi G, Nybo M, et al. Compliance of blood sampling procedures with CLSI H3-A6 standard for the collection of diagnostic blood specimens by venipuncture and risk assessment analysis: an observational study by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) working group for the preanalytical phase (WG-PRE). Clin Chem Lab Med 2015;53:1321–31.10.1515/cclm-2014-1053Suche in Google Scholar PubMed

15. Plebani M, Sciacovelli L, Aita A, Chiozza ML. Harmonization of pre-analytical quality indicators. Biochem Med (Zagreb) 2014;24:105–13.10.11613/BM.2014.012Suche in Google Scholar PubMed PubMed Central

16. Plebani M, Astion ML, Barth JH, Chen W, de Oliveira Galoro CA, Escuer MI, et al. Harmonization of quality indicators in laboratory medicine. A preliminary consensus. Clin Chem Lab Med 2014;52:951–8.Suche in Google Scholar

17. Simundic AM, Cornes M, Grankvist K, Lippi G, Nybo M, Kovalevskaya S, et al. Survey of national guidelines, education and training on phlebotomy in 28 European countries: an original report by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) working group for the preanalytical phase (WG-PA). Clin Chem Lab Med 2013;51:1585–93.10.1515/cclm-2013-0283Suche in Google Scholar PubMed

18. Zima T. Accreditation in clinical laboratories. Biochem Med (Zagreb) 2010;20:215–20.10.11613/BM.2010.026Suche in Google Scholar

19. Ho B, Ho E. The most common nonconformities encountered during the assessments of medical laboratories in Hong Kong using ISO 15189 as accreditation criteria. Biochem Med (Zagreb) 2012;22:247–57.10.11613/BM.2012.027Suche in Google Scholar

20. Simundic AM, Nikolac N, Ivankovic V, Ferenec-Ruzic D, Magdic B, Kvaternik M, et al. Comparison of visual versus automated detection of lipemic, icteric and hemolyzed specimens: can we rely on a human eye? Clin Chem Lab Med 2009;47:1361–5.10.1515/CCLM.2009.306Suche in Google Scholar PubMed

21. Lippi G, Avanzini P, Campioli D, Da Rin G, Dipalo M, Aloe R, et al. Systematical assessment of serum indices does not impair efficiency of clinical chemistry testing: a multicenter testing. Clin Biochem 2013;46:1281–4.10.1016/j.clinbiochem.2013.06.007Suche in Google Scholar PubMed

22. Kocak FE, Meral A, Kocak H. Assessment of serum indices implementation on Roche Cobas 6000 analyzer. Eur J Med Sci 2014;1:43–52.10.12973/ejms.2014.109pSuche in Google Scholar

23. Dolci A, Panteghini M. Harmonization of automated hemolysis index assessment and use: Is it possible? Clin Chim Acta 2014;432:38–43.10.1016/j.cca.2013.10.012Suche in Google Scholar PubMed

24. Fliser E, Jerkovic K, Vidovic T, Gorenjak M. Investigation of unusual high serum indices for lipemia in clear serum samples on siemens analysers dimension. Biochem Med (Zagreb) 2012;22:352–62.10.11613/BM.2012.037Suche in Google Scholar

25. Fernandez P, Llopis MA, Perich C, Alsina MJ, Alvarez V, Biosca C, et al. Harmonization in hemolysis detection and prevention. A working group of the Catalonian Health Institute (ICS) experience. Clin Chem Lab Med 2014;52:1557–68.Suche in Google Scholar

26. Nikolac N, Simundic AM, Miksa M, Lima-Oliveira G, Salvagno GL, Caruso B, et al. Heterogeneity of manufacturers’ declarations for lipemia interference – An urgent call for standardization. Clin Chim Acta 2013;426:33–40.10.1016/j.cca.2013.08.015Suche in Google Scholar PubMed

27. Nikolac N. Lipemia: causes, interference mechanisms, detection and management. Biochem Med 2014;24:57–67.10.11613/BM.2014.008Suche in Google Scholar PubMed PubMed Central

28. Dimeski G. Interference testing. Clin Biochem Rev 2008;29(Suppl 1):S43–8.Suche in Google Scholar

29. Sandberg S, Fraser CG, Horvath AR, Jansen R, Jones G, Oosterhuis W, et al. Defining analytical performance specifications: Consensus Statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem Lab Med 2015;53:833–5.10.1515/cclm-2015-0067Suche in Google Scholar PubMed

30. Szoke D, Braga F, Valente C, Panteghini M. Hemoglobin, bilirubin, and lipid interference on Roche Cobas 6000 assays. Clin Chim Acta 2012;413:339–41; author reply 342–3.10.1016/j.cca.2011.09.044Suche in Google Scholar PubMed

31. Plebani M, Sciacovelli L, Aita A, Pelloso M, Chiozza ML. Performance criteria and quality indicators for the pre-analytical phase. Clin Chem Lab Med 2015;53:943–8.10.1515/cclm-2014-1124Suche in Google Scholar PubMed

32. Allen LC. Role of a quality management system in improving patient safety – laboratory aspects. Clin Biochem 2013;46:1187–93.10.1016/j.clinbiochem.2013.04.028Suche in Google Scholar PubMed

33. Lippi G, Chance JJ, Church S, Dazzi P, Fontana R, Giavarina D, et al. Preanalytical quality improvement: from dream to reality. Clin Chem Lab Med 2011;49:1113–26.10.1515/CCLM.2011.600Suche in Google Scholar PubMed

34. ISO 15189:2012. Medical laboratories – Requirements for quality and competence. Geneva, Switzerland: International Organization for Standardization, 2012.Suche in Google Scholar

Received: 2015-7-9
Accepted: 2015-8-28
Published Online: 2015-9-30
Published in Print: 2016-3-1

©2016 by De Gruyter

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. The way of prostate cancer diagnostics
  4. Review
  5. Statistical methods used in the calculation of geriatric reference intervals: a systematic review
  6. Opinion Paper
  7. The side effects of translational omics: overtesting, overdiagnosis, overtreatment
  8. Genetics and Molecular Diagnostics
  9. Rapid detection of non-deletional mutations causing α-thalassemia by multicolor melting curve analysis
  10. General Clinical Chemistry and Laboratory Medicine
  11. Patient pools and the use of “patient means” are valuable tools in quality control illustrated by a bone-specific alkaline phosphatase assay
  12. Long-term stability of glucose: 96-h study using Terumo Glycaemia tubes
  13. Glucose is stable during prolonged storage in un-centrifuged Greiner tubes with liquid citrate buffer, but not in serum and NaF/KOx tubes
  14. Croatian laboratories have a good knowledge of the proper detection and management of hemolyzed, icteric and lipemic samples
  15. Fetal exposure to ethanol: relationship between ethyl glucuronide in maternal hair during pregnancy and ethyl glucuronide in neonatal meconium
  16. Comparing the effect of isotopically labeled or structural analog internal standards on the performance of a LC-MS/MS method to determine ciclosporin A, everolimus, sirolimus and tacrolimus in whole blood
  17. Relationship between matrix metalloproteinase-9 and oxidative stress in drug-free male schizophrenia: a case control study
  18. Comparison of functional fibrinogen (FF/CFF) and FIBTEM in surgical patients – a retrospective study
  19. Reference Values and Biological Variations
  20. Assessment of serum free light chain levels in healthy adults immediately after marathon running
  21. Pharmacokinetics of a novel dosing regimen of oral melatonin in critically ill patients
  22. Cancer Diagnostics
  23. An epidemiology-based model as a tool to monitor the outbreak of inappropriateness in tumor marker requests: a national scale study
  24. Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomes
  25. Infectious Diseases
  26. Comparative evaluation of the Aptima HIV-1 Quant Dx assay and COBAS TaqMan HIV-1 v2.0 assay using the Roche High Pure System for the quantification of HIV-1 RNA in plasma
  27. Evaluating the use of procalcitonin in an asymptomatic, HIV-infected antiretroviral therapy-naïve, South African cohort
  28. Diabetes
  29. Early prediction of gestational diabetes: a practical model combining clinical and biochemical markers
  30. Letters to the Editors
  31. Highly-trained dogs’ olfactory system for detecting biochemical recurrence following radical prostatectomy
  32. More on the accuracy of the Architect enzymatic assay for hemoglobin A1c and its traceability to the IFCC reference system
  33. Assessing quality from an accuracy-based HbA1c proficiency survey
  34. HbG-Honolulu interferes with some cation-exchange HPLC HbA1c assays
  35. Between analyser differences in chloride measurements and thus anion gap cause different interpretations of the acid-base balance
  36. Non-albumininuric proteinuria: a urinary tubular marker in the diagnosis of diabetic kidney disease
  37. International Normalized Ratio (INR) testing: analytical and clinical performance of four point-of-care devices versus central laboratory instrumentation analysis
  38. Genetic screening of the makorin ring finger 3 gene in girls with idiopathic central precocious puberty
  39. Practical approach for medical validation of therapeutic drug monitoring results
  40. Marked elevation of procalcitonin in a patient with a drug related infusion reaction to rituximab
https://doi.org/10.1515/cclm-2015-0650
Schlagwörter für diesen Artikel
hemolysis; icteria; interferences; laboratory errors; lipemia; preanalytical phase; survey

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. The way of prostate cancer diagnostics
  4. Review
  5. Statistical methods used in the calculation of geriatric reference intervals: a systematic review
  6. Opinion Paper
  7. The side effects of translational omics: overtesting, overdiagnosis, overtreatment
  8. Genetics and Molecular Diagnostics
  9. Rapid detection of non-deletional mutations causing α-thalassemia by multicolor melting curve analysis
  10. General Clinical Chemistry and Laboratory Medicine
  11. Patient pools and the use of “patient means” are valuable tools in quality control illustrated by a bone-specific alkaline phosphatase assay
  12. Long-term stability of glucose: 96-h study using Terumo Glycaemia tubes
  13. Glucose is stable during prolonged storage in un-centrifuged Greiner tubes with liquid citrate buffer, but not in serum and NaF/KOx tubes
  14. Croatian laboratories have a good knowledge of the proper detection and management of hemolyzed, icteric and lipemic samples
  15. Fetal exposure to ethanol: relationship between ethyl glucuronide in maternal hair during pregnancy and ethyl glucuronide in neonatal meconium
  16. Comparing the effect of isotopically labeled or structural analog internal standards on the performance of a LC-MS/MS method to determine ciclosporin A, everolimus, sirolimus and tacrolimus in whole blood
  17. Relationship between matrix metalloproteinase-9 and oxidative stress in drug-free male schizophrenia: a case control study
  18. Comparison of functional fibrinogen (FF/CFF) and FIBTEM in surgical patients – a retrospective study
  19. Reference Values and Biological Variations
  20. Assessment of serum free light chain levels in healthy adults immediately after marathon running
  21. Pharmacokinetics of a novel dosing regimen of oral melatonin in critically ill patients
  22. Cancer Diagnostics
  23. An epidemiology-based model as a tool to monitor the outbreak of inappropriateness in tumor marker requests: a national scale study
  24. Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomes
  25. Infectious Diseases
  26. Comparative evaluation of the Aptima HIV-1 Quant Dx assay and COBAS TaqMan HIV-1 v2.0 assay using the Roche High Pure System for the quantification of HIV-1 RNA in plasma
  27. Evaluating the use of procalcitonin in an asymptomatic, HIV-infected antiretroviral therapy-naïve, South African cohort
  28. Diabetes
  29. Early prediction of gestational diabetes: a practical model combining clinical and biochemical markers
  30. Letters to the Editors
  31. Highly-trained dogs’ olfactory system for detecting biochemical recurrence following radical prostatectomy
  32. More on the accuracy of the Architect enzymatic assay for hemoglobin A1c and its traceability to the IFCC reference system
  33. Assessing quality from an accuracy-based HbA1c proficiency survey
  34. HbG-Honolulu interferes with some cation-exchange HPLC HbA1c assays
  35. Between analyser differences in chloride measurements and thus anion gap cause different interpretations of the acid-base balance
  36. Non-albumininuric proteinuria: a urinary tubular marker in the diagnosis of diabetic kidney disease
  37. International Normalized Ratio (INR) testing: analytical and clinical performance of four point-of-care devices versus central laboratory instrumentation analysis
  38. Genetic screening of the makorin ring finger 3 gene in girls with idiopathic central precocious puberty
  39. Practical approach for medical validation of therapeutic drug monitoring results
  40. Marked elevation of procalcitonin in a patient with a drug related infusion reaction to rituximab
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2026 De Gruyter Brill
Heruntergeladen am 23.1.2026 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2015-0650/pdf?lang=de
Button zum nach oben scrollen